NBA 3 – Date of Birth Date Time The date of birth Cannot be a Critical identification Supports demographic Failure to accurately Use Transparent – of the patient future date parameter for analysis to support forecast product to some users of maintaining patient short, medium and demand and assess system (see record and data long term Ig demand security of supply security matrix) integrity - supports forecasting to assure the patient may not Disclosure not – correct patient record security of supply. always obtain the intended for access and Enables performance product that they release other than identification during analysis of product need. contained in system search by user. and treatment Loss of evidence aggregated data protocol efficacy by (Authoriser, Prescriber, supporting product sets. age. Nurse, Dispenser) efficacy and optimising NBA 7 treatment protocols. – NBA -3 Sex LOV: Gender The sex of the Valid Values: Critical identification Reduces likelihood of Patient safety risk due Use Transparent – patient parameter for duplicate patient to increased risk of to some users of Female maintaining patient records being created prescriber linking system (see Male record and data when used with DOB condition to wrong security matrix) Unknown integrity and other patient record leading to Disclosure not – names. incorrect ( Authoriser, Prescriber, intended for authorisation, Nurse, Dispenser) release other than prescription dose, contained in
NBA – 3 Date of Birth Date Time The date of birth of the patient Cannot be a future date Critical identification parameter for maintaining patient record and data integrity - supports correct patient record access and identification during system search by user. (Authoriser, Prescriber, Nurse, Dispenser) NBA -3 Supports demographic analysis to support short, medium and long term Ig demand forecasting to assure security of supply. Enables performance analysis of product and treatment protocol efficacy by age. NBA – 7 Failure to accurately forecast product demand and assess security of supply the patient may not always obtain the product that they need. Loss of evidence supporting product efficacy and optimising treatment protocols. Use – Transparent to some users of system (see security matrix) Disclosure – not intended for release other than contained in aggregated data sets. Sex LOV: Gender The sex of the patient Valid Values: Female Male Unknown Critical identification parameter for maintaining patient record and data integrity ( Authoriser, Prescriber, Nurse, Dispenser) Reduces likelihood of duplicate patient records being created when used with DOB and other patient names. Patient safety risk due to increased risk of prescriber linking condition to wrong record leading to incorrect authorisation, prescription dose, Use – Transparent to some users of system (see security matrix) Disclosure – not intended for release other than contained in